X-Nico

unusual facts about Sanofi-Aventis



Active ingredient

While Aesica, Piramal, MSD (Northumberland), Sanofi (Tyne & Wear) and GlaxoSmithKline (County Durham) are all secondary pharmaceutical manufacturers who formulate and package API's for consumer use.

Aventis School of Management

On April 9, Aventis in collaboration with Zicklin School of Business hosted the Annual Public Lecture Series-Beyond The Financial Crisis: Ethics & Professional Responsibilities by Professor Larry Zicklin who endowed the Wharton's Carol and Lawrence Zicklin Center for Business Ethics Research and the Robert Zicklin Center for Corporate Integrity (CCI) at Baruch College.

Aventis School of Management is listed in the TOP MBA Career Guide 2010 from peer surveys by Quacquarelli Symonds.

Buserelin

Buserelin acetate is marketed by Sanofi-Aventis under the brand name Suprefact and a generic form of Buserelin is now produced by CinnaGen under the brand name CinnaFact.

Havas Worldwide

Havas Worldwide works with 78 of the 100 largest global advertisers including Air France, BNP Paribas, Citigroup, Danone Group, IBM, Kraft Foods, Lacoste, Merck, Pernod Ricard, PSA Peugeot Citroën, Reckitt Benckiser, Sanofi, and Volvo.

Judy Lewent

Since then Lewent has also been responsible for Merck's collaboration with Johnson & Johnson in a consumer pharmaceuticals joint venture, for the setting up of the animal health company Merial (a joint venture with the French pharmaceutical company Sanofi-Aventis), and for Merck's ongoing relationships with AstraZeneca and DuPont.

Marc de Garidel

He is President and spokesperson for G5 santé, a lobbying group for French pharmaceutical companies, including BioMérieux, Guerbet, Ipsen, the Laboratoire français du Fractionnement et des Biotechnologies, Laboratoires Pierre Fabre, Sanofi, Stallergenes and Laboratoires Théa.

Ombrabulin

Ombrabulin is an experimental drug candidate discovered by Ajinomoto and under development by Sanofi-Aventis.

PatientsLikeMe

Some of PatientsLikeMe’s past and present partners include UCB, Novartis, Sanofi, Avanir Pharmaceuticals and Acorda Therapeutics.

StarLink corn recall

The Garst Seed Company (part of the Advanta group) was licensed by Aventis to produce and sell StarLink seed in the US.

In 2003, farmers who did not plant StarLink who had suffered economic losses due to depressed corn prices following the StarLink recalls settled a class-action lawsuit against Aventis and Advanta for $100 million.

Tofogliflozin

Tofogliflozin (USAN, codenamed CSG452) is an experimental drug for the treatment of diabetes mellitus and is being developed by Chugai Pharma in collaboration with Kowa and Sanofi.

Witham on the Hill

In 2002, West Farm (on the Little Bytham road) had trials for GM Rapeseed planted by Aventis.

Z-drug

Z drugs emerged in the last years of the 1980s and early 1990s, with zopiclone (Imovane) approved by the NHS as early as 1989, quickly followed by Sanofi and zolpidem (Ambien).


see also